Announcements Trials
Browse Landscape

Status

Completed 11Unknown 3Not yet recruiting 3Recruiting 2Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 20Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Myeloid 1

Conditions

Neoplasms 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hematologic Neoplasms 1

Interventions

Blood Specimen Collection 121Surveys and Questionnaires 83Observation 50Radiotherapy 40Drug Therapy 35Surgical Procedures, Operative 34Biopsy 31Specimen Handling 28Data Collection 28Watchful Waiting 21Interviews as Topic 20Immune Checkpoint Inhibitors 19Magnetic Resonance Imaging 18Liquid Biopsy 16Immunotherapy 15Magnetic Resonance Spectroscopy 14Standard of Care 13pembrolizumab 12Tomography, X-Ray Computed 12Ultrasonography 11trastuzumab deruxtecan 10lenvatinib 10Radiosurgery 10Nivolumab 10Carboplatin 10Tissue Banks 9Restraint, Physical 9Radiation 9Neoadjuvant Therapy 9Endoscopy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Observational × Imatinib Mesylate × Clear all
NCT05282108 2025-03-26

CARCML

Hikma Pharmaceuticals LLC

Recruiting
240 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

NCT05467189 2022-07-20

Antineoplastic Drugs in Elderly Patients

Shandong University

Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡